No Data
No Data
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
Is Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Worth US$2.7 Based On Its Intrinsic Value?
Sonoma Pharmaceuticals GAAP EPS of -$0.63 Beats by $0.06, Revenue of $3.6M Misses by $0.46M
Sonoma Pharmaceuticals | 10-Q: Q3 2025 Earnings Report
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
Unlock the Full List